fda glp-1 warning september 2025 Beyond the Headlines: Letters to Compounders fda glp-1 warning letters september

Across diabetes and obesity, there are ~20 novel GLP-1 agonists and multi-agonists in Phase 2/3 development (see image 2) , with a host more in earlier stages

[DOI] [PubMed] [Google Scholar] Saghafian F, Malmir H, Saneei P, Milajerdi A, Larijani B, Esmaillzadeh A

The MHRA also advises consumers to be wary of weight loss products making exaggerated claims and warns that some products sold online as slimming aids have been found to contain undeclared pharmaceutical substances or dangerous stimulants

Kang DH, Kang SW

Additionally, cholesterols mechanism includes increasing chain order in liquid-state bilayers while reducing it in gel-state bilayers, transforming the gel phase gradually into a liquid-ordered state

In summary, VAX-D shows promising results in reducing pain and nerve compression in some patients, but it also carries possible risks